SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1055)2/25/1998 5:23:00 PM
From: Biomaven  Read Replies (1) of 2742
 
Rick,

The swing in shares outstanding is because of the new FAS 128 rules. Because the company had an operating loss for one of the quarters, the options are ignored for that quarter, as they are anti-dilutive (i.e., they would _decrease_ the loss per share by increasing the number of shares outstanding).

I've never been a CIST shareholder, but the excess of book value over share price is keeping me looking at it closely. Any chance they might just liquidate it?

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News